A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ITEM 1 — BUSINESS LifeVantage Corporation (the “Company,” “LifeVantage,” “we,” “us,” or “our”) is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. LifeVantage is dedicated to helping people achieve their health, wellness and financial goals. We provide quality, scientifically validated products to customers and independent consultants as well as a financially rewarding commission-based direct sales opportunity to our independent consultants. We sell our products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and Singapore. We also sell our products in a number of countries to customers for personal consumption only.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 210M | 229M | 200M | 213M | 206M | 220M |
| Net Income | 7.9M | 9.8M | 2.9M | 2.5M | 3.1M | 13M |
| EPS | $0.60 | $0.75 | $0.23 | $0.20 | $0.24 | $0.90 |
| Free Cash Flow | 1.7M | 11M | 10.0M | 3.8M | 6.4M | 13M |
| ROIC | 33.2% | 32.2% | 11.3% | 7.8% | 16.0% | 35.8% |
| Gross Margin | 78.7% | 80.4% | 79.3% | 79.7% | 81.5% | 82.7% |
| Debt/Equity | 0.00 | 1.08 | 1.32 | 0.91 | 1.24 | 1.14 |
| Dividends/Share | $0.17 | $0.17 | $0.55 | $0.12 | $0.03 | $0.00 |
| Operating Income | 9.0M | 12M | 4.3M | 4.3M | 7.6M | 18M |
| Operating Margin | 4.3% | 5.3% | 2.2% | 2.0% | 3.7% | 8.0% |
| ROE | 23.8% | 32.3% | 11.3% | 7.3% | 9.9% | 35.0% |
| Shares Outstanding | 13M | 13M | 13M | 13M | 13M | 14M |
Lifevantage Corp passes 5 of 9 quality checks, suggesting mixed fundamentals.
Lifevantage Corp trades at 6.9x trailing earnings, compared to its 15-year median P/E of 18.4x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 31.2x vs a median of 9.9x. The company's 5-year average ROIC is 20.6% with a gross margin of 80.7%. Total shareholder yield (dividends + buybacks) is 9.1%. At current prices, the estimated annualized return to fair value is -9.0%.
Lifevantage Corp (LFVN) has a current P/E ratio of 6.9, compared to its historical median P/E of 18.4. The stock is currently considered Cheap based on its historical valuation range.
Lifevantage Corp (LFVN) has a 5-year average return on invested capital (ROIC) of 20.6%. This indicates strong capital allocation and a potential competitive advantage.
Lifevantage Corp (LFVN) has a market capitalization of $53M. It is classified as a small-cap stock.
Yes, Lifevantage Corp (LFVN) pays a dividend with a trailing twelve-month yield of 4.18%. The company also returns capital through share buybacks, with a buyback yield of 4.93%.
Based on historical P/E analysis, Lifevantage Corp (LFVN) appears cheap. The current P/E of 6.9 is 63% below its historical median of 18.4. The estimated fair value CAGR (P/E method) is -9.5%.
Lifevantage Corp (LFVN) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
Lifevantage Corp (LFVN) reported annual revenue of $229 million in its most recent fiscal year, based on SEC EDGAR filings.
Lifevantage Corp (LFVN) has a net profit margin of 4.3%. This is a modest margin.
Lifevantage Corp (LFVN) generated $11 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Lifevantage Corp (LFVN) has a debt-to-equity ratio of 1.08. This indicates moderate leverage.
Lifevantage Corp (LFVN) reported earnings per share (EPS) of $0.75 in its most recent fiscal year.
Lifevantage Corp (LFVN) has a return on equity (ROE) of 32.3%. This indicates the company generates strong returns for shareholders.
Lifevantage Corp (LFVN) has a 5-year average gross margin of 80.7%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 15 years of financial data for Lifevantage Corp (LFVN), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Lifevantage Corp (LFVN) has a book value per share of $2.65, based on its most recent annual SEC filing.
No recent press releases.